{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:18:32Z","timestamp":1740122312807,"version":"3.37.3"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11060-015-2053-1","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T01:25:38Z","timestamp":1451957138000},"page":"405-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to: methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial"],"prefix":"10.1007","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-3275","authenticated-orcid":false,"given":"Ian J.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,5]]},"reference":[{"key":"2053_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-015-1878-y","volume":"125","author":"DI Sandberg","year":"2015","unstructured":"Sandberg DI, Rytting M, Zaky W, Kerr M, Ketonen L, Kundu U, Bartlett D, Moore BL, Yang G, Hou P, Sitton C, Cooper LJ, Gopalakrishnan V, Lee DA, Thall PF, Khatua S (2015) Methotrexate administration directly into the fourth ventricle\u00a0in children with malignant fourth ventricular brain tumors: a pilot clinical trial. J Neurooncol 125:133\u2013141","journal-title":"J Neurooncol"},{"key":"2053_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pbc.24770","volume":"61","author":"IJ Cohen","year":"2014","unstructured":"Cohen IJ, Wolff JE (2014) How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity. Pediatr Blood Cancer 61:7\u201310","journal-title":"Pediatr Blood Cancer"},{"key":"2053_CR3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.mehy.2013.08.027","volume":"31","author":"IJ Cohen","year":"2013","unstructured":"Cohen IJ (2013) Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX). Med Hypotheses 31:942\u2013947","journal-title":"Med Hypotheses"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2053-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-2053-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2053-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:22:58Z","timestamp":1559348578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-2053-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,5]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2053"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-2053-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2016,1,5]]}}}